Navigation Links
Stemedica Announces Completion of Clinical Stem Cell Master Bank

SAN DIEGO, Sept. 14 /PRNewswire/ -- Stemedica Cell Technologies, Inc., a world leader in adult stem cell manufacturing and research, announced today that it has completed its proprietary master bank of mesenchymal bone marrow-derived stem cells. The master cell bank was manufactured in accordance with FDA Good Manufacturing Practices (cGMP). The cell bank has successfully passed all the necessary safety testing required by the FDA and is in compliance with the U.S. Code of Federal Regulations.  Stem cells from the master bank will be used to support clinical trials in the United States and worldwide. The master bank together with its parent bank has the capacity to treat up to 300,000 patients participating in approved clinical trials.

The master bank has been created at the Company's San Diego cGMP manufacturing facility, which is licensed by the State of California's Department of Public Health, Food and Drug Branch to produce stem cells, drugs and biologic products for human clinical trials.  Stem cells from the master bank will be used in the Company's current FDA-approved clinical trial for ischemic stroke in the United States.  There are over 750,000 strokes each year in the United States resulting in 160,000 deaths. In addition, there currently is no treatment option available for the thousands that are left with severe disabilities.

"Stemedica's stem cells will also be provided to sites in various countries that have already received regulatory approval to conduct clinical trials using Stemedica's products," stated, Nikolai Tankovich, MD, PhD, Stemedica's President and Chief Medical Officer. "We have a pending Investigational New Drug application to conduct a clinical trial outside the United States for vascular dementia, the most common form of dementia.  Alzheimer's represents a subgroup of this condition.  Researchers in the United States will now have access to Stemedica stem cells for preclinical studies; cells with predictability and reproducible potency."

"This is a significant milestone in fulfilling our Company's commitment to provide stem cells for clinical trials designed to help people suffering with medical conditions for which there are no other options," said Maynard Howe, PhD,  Stemedica's Chief Executive Officer. "We will now be able to supply our proprietary stem cells to our research and clinical trial partners worldwide."

The Company is in the process of developing master and parent cell banks for additional stem cell lines including neural cells and retinal pigment epithelial cells produced for human use. Management believes that these master cell and parent cell banks are essential to meet the growing demand for stem cell products worldwide.

About Stemedica Cell Technologies, Inc.

Stemedica Cell Technologies, Inc. ( is a specialty biopharmaceutical company that is committed to the development and manufacturing of best-in-class adult stem cells and stem cell factors for use by approved research institutions and hospitals for preclinical and human clinical trials. Stemedica is headquartered in San Diego, California.

For more information regarding this media release or Stemedica Cell Technologies, contact Dave McGuigan at

SOURCE Stemedica Cell Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Stemedica Announces the Appointment of Dr. Csar Amescua Garcia as Medical and Regulatory Affairs Director – Latin America
2. Stemedica Announces the Appointment of Dr. Lev Verkh as Chief Regulatory and Clinical Development Officer
3. Stemedica Completes Meeting with the FDA
4. United States Patent and Trademark Office Publishes Stemedica's Patent Application for the Treatment of Diabetic Retinopathy
5. The Jordanian Stem Cell Company Acquires Stem Cell Technology From Stemedica International S.A. - First Clinical Trail Anticipated To Begin Early 2010
6. Stemedica Achieves Major Milestone - Company Receives License to Manufacture Clinical Grade Stem Cells
7. Stemedica Selected By World Stem Cell Summit To Present Scientific Discoveries
8. Stemedica Requests Pre-IND Meeting With FDA
9. Stemedica Signs Scientific Advisory Board Agreement with Leading Pediatric Burn & Wound Care Researcher
10. Renowned Stem Cell Researcher Files Study Results With Stemedica
11. CIRM Completes Briefing Visit to Stemedica Cell Technologies
Post Your Comments:
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the Industry Network ... Supplyframe Design Lab . Located in Pasadena, Calif., the Design Lab’s mission is ... projects are designed, built and brought to market. , The Design Lab is ...
(Date:6/23/2016)...  Blueprint Bio, a company dedicated to identifying, protecting ... has closed its Series A funding round, according to ... "We have received a commitment from Forentis Fund that ... meet our current goals," stated Matthew Nunez . ... complete validation on the current projects in our pipeline, ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... regulatory and technical consulting, provides a free webinar on Performing Quality ... 13, 2016 at 12pm CT at no charge. , Incomplete investigations are still ...
(Date:6/22/2016)... 2016 Cell Applications, Inc. and StemoniX ... produce up to one billion human induced pluripotent ... week. These high-quality, consistent stem cells enable researchers ... spend more time doing meaningful, relevant research. This ... manufacturing process that produces affordable, reliable HiPSC for ...
Breaking Biology Technology:
(Date:6/9/2016)... 9, 2016 Paris Police ... video security solution to ensure the safety of people and ... during the major tournament Teleste, an international technology ... services, announced today that its video security solution will be ... back up public safety across the country. The system roll-out ...
(Date:6/2/2016)... LONDON , June 2, 2016 ... has awarded the 44 million US Dollar project, ... Security Embossed Vehicle Plates including Personalization, Enrolment, and IT Infrastructure ... world leader in the production and implementation of Identity Management ... in January, however Decatur was selected ...
(Date:6/1/2016)... June 1, 2016 Favorable Government ... Administration and Criminal Identification to Boost Global Biometrics System ... released TechSci Research report, " Global Biometrics Market ... Forecast and Opportunities, 2011 - 2021", the global biometrics ... 2021, on account of growing security concerns across various ...
Breaking Biology News(10 mins):